Clarivate (a research consultancy) are looking for adults in the US who have been diagnosed with all of the following: Type 2 Diabetes (T2DM) AND Peripheral Arterial Disease (PAD) AND “Intermittent claudication,” which means pain in your legs when you’re walking or exercising, which goes away when you rest. If you meet these criteria, Clarivate would like to invite you to take part in one 45-minute interview. The purpose of
At Global Patients we are looking for adults in the US who are living with amyotrophic lateral sclerosis (ALS) to take part in a 60-minute interview.
We are looking for adults with Hepatocellular Carcinoma (HCC) in the US to take part in a single 60-minute, online interview. The purpose of the interview is to understand how individuals with HCC experience their condition and their perspectives on treatments. Participation is entirely voluntary, and your personal information will be kept confidential. You will be compensated $185 to thank you for your time. If you are interested in participating
Global Patients along with IQVIATM, a worldwide healthcare consulting firm, is currently conducting a research study, to better understand the experience of patients living with metastatic pancreatic cancer. We would like to invite you to participate in this study, which includes a 60-minute semi-structured interview with one of our senior healthcare researchers. The interview will focus on your experience with metastatic pancreatic cancer. We are interested in learning about the
Please, find the Spanish description below: Have you been diagnosed with multiple myeloma and are you aged 18 years or older? If so, you may be eligible to participate in an online survey that is being conducted on behalf of a pharmaceutical company to learn about the perspectives of people with multiple myeloma. The purpose of this study is to learn more about the experiences of people living with multiple myeloma
Global Patients is collaborating on a research study to better understand and assess the experience of patients with acute lymphoblastic leukemia (ALL). The research study is being conducted with IQVIATM, a healthcare research firm (www.iqvia.com), and a pharmaceutical company that is working on developing therapies for patients with ALL. We are seeking patients with ALL who: are age 55 and older are age 40-55 who have comorbidities that make them
At Global Patients we are looking for adults who have been diagnosed with advanced/metastatic Renal cell carcinoma to complete an online survey.
Participants will be asked questions about their experience with renal cell carcinoma and perceptions of treatments.
As a token of appreciation they will be compensated with 50USD upon completion.
If you are interested in participating please contact us at firstname.lastname@example.org
Une étude menée par IQVIA, une société de recherche en soins de santé pour le comte de Takeda, visant à mieux comprendre les facteurs que les patient(e)s prennent en considération lorsqu’ils/elles décident où ils/elles souhaiteront recevoir un traitement par perfusion. A cette fin, l’équipe d’étude invite les patient(e)s à remplir un questionnaire en ligne unique sur les préférences des patient(e)s concernant leurs traitements par perfusion dans différents contextes. L’équipe souhaite
Este estudio realizado por IQVIA, una empresa de investigación en salud, en representación de Takeda, tiene como objetivo entender mejor qué tipo de factores tienen en cuenta los pacientes a la hora de escoger el entorno en el que recibirán un tratamiento de infusión. Para evaluarlo, el equipo del estudio invita a los pacientes a completar una única encuesta en internet que analiza las preferencias del paciente cuando recibe un
A study conducted by IQVIA, a healthcare research firm on behalf of Takeda, is aiming to better understand the factors patients take into consideration when deciding the setting where to receive an infusion treatment. We are currently searching for cTTP (Congenital thrombotic thrombocytopenic purpura) patients in the US who currently receive infusion treatments into a vein for a 40min online survey. To assess this, the study team is inviting patients to
A study conducted by IQVIA, a healthcare research firm on behalf of Takeda, is aiming to better understand the factors patients take into consideration when deciding the setting where to receive an infusion treatment. To assess this, the study team is inviting patients to complete a one-time, online survey exploring patient’s preferences for receiving an infusion treatment in different settings. The team is interested in recruiting patients who currently receive
RTI International (RTI), a non-profit research organization, is recruiting people to participate in a focus group. You will be asked questions about your experience with Myasthenia Gravis treatment. If you are 18 years or older and have been told by a doctor that you have Myasthenia Gravis, you may qualify. The focus group will take about 90 minutes and you will be required to read some material before the focus
We currently have a study in the US/UK/ES/FR/IT to learn more about the experiences of patients with NSCLC.
The study will consist of a 120-minute web-based focus group with participants from different countries.
Discussion will be in English.
We appreciate the time that patients invest in them, for this reason we offer an incentive of 250USD/200GBP/230EUR as a token of appreciation.
If you need more information or are interested, please contact us at email@example.com
Global Patients is collaborating on a research study with IQVIA™, a worldwide healthcare consulting firm, and a pharmaceutical company. The aim is to explore the symptoms of prostate cancer and how they have impacted the quality of life of patients and get feedback on a questionnaire designed to assess symptoms. We are seeking patients who have been diagnosed with either metastatic hormone sensitive (mHSPC) or metastatic castration resistant prostate cancer
At Global Patients we have launched a study to learn more about cardiovascular patients in the UK.
It would consist of a 60-90minute web-assisted interview and participants would receive 120GBP upon completion. There is no medication intake related to the study, we are only interested in opinions.
If you wish to learn more, please contact us at firstname.lastname@example.org
At Global Patients we are launching a new study to understand specific experiences of patients and caregivers of MDS (Myelodysplastic syndrome) in Canada.
Eligible participants will complete a 60min telephone interview and receive a 128CAD incentive as a token of appreciation for their time.
If you are interested in participating or know anyone who might, please contact us at email@example.com